← Back to Clinical Trials
Recruiting NCT04164173
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
Trial Parameters
Condition Pulmonary Disease
Sponsor University of Texas Southwestern Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 324
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2020-06-15
Completion 2028-08-01
All Conditions
Interventions
EzPAPMetanebIntermittent Positive Pressure Breathing (IPPB)
Brief Summary
The purpose of this prospective randomized clinical trial is to evaluate three different types of hyperinflation respiratory therapies, Intermittent Positive Pressure Breathing (IPPB), Intermittent positive end expiratory pressure (EzPAP), Metaneb. Investigators will examine which hyperinflation therapy provides better lung expansion and may improve lung recovery after surgery.
Eligibility Criteria
Inclusion Criteria: 1. Age 18 years and older 2. Admitted to Cardiovascular ICU (CVICU) after coronary artery bypass grafting (CABG), isolated valve repair/replacement, or CABG + valve repair/replacement 3. Cardiac surgery performed via median sternotomy Exclusion Criteria: 1. BMI\>40 2. Refusal to be consented 3. Prior or current lung transplant patients